April 4 (Reuters) - Australian Competition and Consumer Commission (ACCC):
* WILL NOT OPPOSE REVISED COCHLEAR, OTICON TRANSACTION
* CONSIDERS IT UNLIKELY THAT OTICON MEDICAL WOULD HAVE BECOME A STRONGER COMPETITOR IN SUPPLY OF COCHLEAR IMPLANTS IN FORESEEABLE FUTURE
* SATISFIED THAT ITS COMPETITION CONCERNS WITH RESPECT TO BONE CONDUCTION SOLUTIONS ARE ADDRESSED
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments